日本語English简体中文 繁體中文

4548 SEIKAGAKU CORPORATION生化学工業TSE Prime / Pharmaceuticals

0 posts

SEIKAGAKU CORPORATION (4548) at a glance

Code
4548
Company
SEIKAGAKU CORPORATION
Local name
生化学工業
Market
TSE Prime
Sector
Pharmaceuticals
Share price
¥522 -10.0 (-1.88%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

SEIKAGAKU CORPORATION (4548) Stock Price HistoryNear an all-time low

SEIKAGAKU CORPORATION closed at ¥522 on Nov 20, 2026, −7.9% over 1 month, −21.3% over 1 year.

2026-11-10 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結) / 2027年3月期通期連結業績予想の修正に関するお知らせ¥573¥522Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥573Oct 26
1-Month Low¥522Nov 20
1-Week Change−3.0%vs Nov 13
1-Month Change−7.9%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥92,063 today (−7.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −7.9%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥522−10−1.88%
Nov 19 (Thu)¥532−3−0.56%
Nov 18 (Wed)¥535−1−0.19%
Nov 17 (Tue)¥536−4−0.74%
Nov 16 (Mon)¥540+2+0.37%
Nov 13 (Fri)¥538−1−0.19%
Nov 12 (Thu)¥539+4+0.75%
Nov 11 (Wed)¥535−8−1.47%
Nov 10 (Tue)¥543+8+1.50%
Nov 9 (Mon)¥535−5−0.93%
2026-09-24 2027年3月期通期連結業績予想の修正、通期個別業績予想の公表及び配当予想の修正に関…2026-11-10 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結) / 2027年3月期通期連結業績予想の修正に関するお知らせ¥720¥522Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥720Aug 26
3-Month Low¥522Nov 20
1-Month Change−7.9%vs Oct 20
3-Month Change−26.4%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥73,625 today (−26.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −26.4%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥522−10−1.88%
Nov 19 (Thu)¥532−3−0.56%
Nov 18 (Wed)¥535−1−0.19%
Nov 17 (Tue)¥536−4−0.74%
Nov 16 (Mon)¥540+2+0.37%
Nov 13 (Fri)¥538−1−0.19%
Nov 12 (Thu)¥539+4+0.75%
Nov 11 (Wed)¥535−8−1.47%
Nov 10 (Tue)¥543+8+1.50%
Nov 9 (Mon)¥535−5−0.93%
2026-09-24 2027年3月期通期連結業績予想の修正、通期個別業績予想の公表及び配当予想の修正に関…2026-11-10 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結) / 2027年3月期通期連結業績予想の修正に関するお知らせ¥818¥522May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥818May 22
6-Month Low¥522Nov 20
3-Month Change−26.4%vs Aug 20
6-Month Change−33.2%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥66,752 today (−33.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −33.2%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥522−7.0%
Oct 2026¥561−6.5%
Sep 2026¥600−16.6%
Aug 2026¥719−3.6%
Jul 2026¥746+4.0%
Jun 2026¥717−7.4%
May 2026¥774+10.3%
2026-09-24 2027年3月期通期連結業績予想の修正、通期個別業績予想の公表及び配当予想の修正に関…2026-11-10 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結) / 2027年3月期通期連結業績予想の修正に関するお知らせ¥818¥522Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥818May 22
52-Week Low¥522Nov 20
Year to Date−26.6%vs Dec 30
From 52-Week High−36.2%May 22

If you had invested ¥100,000 1 year ago, it would be worth ¥78,733 today (−21.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −21.3%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥522−7.0%
Oct 2026¥561−6.5%
Sep 2026¥600−16.6%
Aug 2026¥719−3.6%
Jul 2026¥746+4.0%
Jun 2026¥717−7.4%
May 2026¥774+10.3%
Apr 2026¥702−3.7%
Mar 2026¥729−7.3%
Feb 2026¥786+12.6%
Jan 2026¥698−1.8%
Dec 2025¥711+2.3%
Nov 2025¥695―
¥900¥522Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥900Jul 8, 2024
3-Year Low¥522Nov 20, 2026
Annualized Return−12.1%
Max Drawdown−42.0%

If you had invested ¥100,000 3 years ago, it would be worth ¥67,880 today (−32.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −32.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥522−26.6%
2025¥711―
¥979¥522Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥979Dec 6, 2021
5-Year Low¥522Nov 20, 2026
Annualized Return−11.8%
Max Drawdown−46.7%

If you had invested ¥100,000 5 years ago, it would be worth ¥53,538 today (−46.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −46.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥522−26.6%
2025¥711―
¥2,286¥522Apr 1, 2004Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥2,286Mar 2015
All-Time Low¥522Nov 2026
Total Change−28.4%vs Apr 2004
Annualized Return−1.5%

If you had invested ¥100,000 in Apr 2004, it would be worth ¥71,616 today (−28.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +375.9%, while this stock moved −28.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥522−26.6%
2025¥711−11.6%
2024¥804+5.7%
2023¥761−15.4%
2022¥899−4.5%
2021¥941−7.5%
2020¥1,017−17.6%
2019¥1,234−1.2%
2018¥1,249−25.7%
2017¥1,680−3.0%
2016¥1,732−4.4%
2015¥1,811−7.6%
2014¥1,959+52.3%
2013¥1,286+39.8%
2012¥920+11.1%
2011¥828−8.9%
2010¥909−6.4%
2009¥971−0.2%
2008¥973−17.5%
2007¥1,180−1.8%
2006¥1,202−6.9%
2005¥1,291+39.3%
2004¥927―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2004). Please check the latest prices before trading.

SEIKAGAKU CORPORATION (4548) financial indicators

PBR
0.39
ROE
-3.72%
Dividend yield
3.83%

See all financial indicators for SEIKAGAKU CORPORATION (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of SEIKAGAKU CORPORATION (4548)

Business overview

Together with 7 subsidiaries, the company researches, develops, manufactures, procures and sells pharmaceuticals and LAL products. In pharmaceuticals it handles drugs such as joint function improvers, ophthalmic surgical aids, a treatment for lumbar disc herniation and a submucosal injection material for endoscopy, as well as active pharmaceutical ingredients, and also provides contract manufacturing of drugs. In North America a subsidiary handles part of its drug and medical device development. In LAL it handles reagents for measuring endotoxin and in vitro diagnostics for measuring glucan.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Pharmaceuticals (79 companies)

Dividend yield3.83%No. 8 in the sector (highest first); median 2.97%
PBR0.39xBelow the sector median of 1.86x (No. 2 from the lowest)
ROE-3.72%No. 38 in the sector (highest first); median 4.17%
Market cap¥28.5 bnNo. 36 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥8185/22
52-week low¥52211/20
Current position0.0%Where the low is 0% and the high is 100% (close on 11/20: ¥522)
Year to date-26.6%No. 49 of 77 in the sector (best first)
1 year-21.3%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 losers1 timesLatest: 9/25 (No. 5)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (3).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the SEIKAGAKU CORPORATION board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English